Literature DB >> 12131102

Sevoflurane but not propofol preserves myocardial function in coronary surgery patients.

Stefan G De Hert1, Pieter W ten Broecke, Els Mertens, Esther W Van Sommeren, Ivo G De Blier, Bernard A Stockman, Inez E Rodrigus.   

Abstract

BACKGROUND: Sevoflurane has been shown to protect against myocardial ischemia and reperfusion injury in animals. The present study investigated whether these effects were clinically relevant and would protect left ventricular (LV) function during coronary surgery.
METHODS: Twenty coronary surgery patients were randomly assigned to receive either target-controlled infusion of propofol or inhalational anesthesia with sevoflurane. Except for this, anesthetic and surgical management was the same in all patients. A high-fidelity pressure catheter was positioned in the left ventricle and the left atrium. LV response to increased cardiac load, obtained by leg elevation, was assessed before and after cardiopulmonary bypass (CPB). Effects on contraction were evaluated by analysis of changes in dP/dt(max). Effects on relaxation were assessed by analysis of the load dependence of myocardial relaxation (R = slope of the relation between time constant tau of isovolumic relaxation and end-systolic pressure). Postoperative concentrations of cardiac troponin I were followed during 36 h.
RESULTS: Before CPB, leg elevation slightly increased dP/dt(max) in the sevoflurane group (5 +/- 3%), whereas it remained unchanged in the propofol group (1 +/- 6%). After CPB, leg elevation resulted in a decrease in dP/dt(max) in the propofol group (-5 +/- 4%), whereas the response in the sevoflurane group was comparable to the response before CPB (5 +/- 4%). Load dependence of LV pressure fall (R) was similar in both groups before CPB. After CPB, R was increased in the propofol group but not in the sevoflurane group. Troponin I concentrations were significantly lower in the sevoflurane than in the propofol group.
CONCLUSIONS: Sevoflurane preserved LV function after CPB with less evidence of myocardial damage in the first 36 h postoperatively. These data suggest a cardioprotective effect of sevoflurane during coronary artery surgery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12131102     DOI: 10.1097/00000542-200207000-00007

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  40 in total

1.  [Preconditioning with sevoflurane reduces biochemical markers for myocardial and renal dysfunction after aortocoronary procedures].

Authors:  S Ziegeler
Journal:  Anaesthesist       Date:  2004-09       Impact factor: 1.041

Review 2.  [Myocardial preconditioning with volatile anesthetics. General anesthesia as protective intervention?].

Authors:  H Buchinger; U Grundmann; S Ziegeler
Journal:  Anaesthesist       Date:  2005-09       Impact factor: 1.041

Review 3.  General anesthesia in cardiac surgery: a review of drugs and practices.

Authors:  Cory M Alwardt; Daniel Redford; Douglas F Larson
Journal:  J Extra Corpor Technol       Date:  2005-06

Review 4.  Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain.

Authors:  Hideto Kitano; Jeffrey R Kirsch; Patricia D Hurn; Stephanie J Murphy
Journal:  J Cereb Blood Flow Metab       Date:  2006-10-18       Impact factor: 6.200

Review 5.  Inflammatory response and cardioprotection during open-heart surgery: the importance of anaesthetics.

Authors:  M-S Suleiman; K Zacharowski; G D Angelini
Journal:  Br J Pharmacol       Date:  2007-10-22       Impact factor: 8.739

6.  Regional wall motion abnormality at the lateral wall disturbs correlations between tissue Doppler E/e' ratios and left ventricular diastolic performance parameters measured by invasive methods.

Authors:  Toshiharu Fujii; Koichiro Yoshioka; Masataka Nakano; Gaku Nakazawa; Mari Amino; Naoki Masuda; Norihiko Shinozaki; Shigetaka Kanda; Nobuhiko Ogata; Yoshiaki Deguchi; Fuminobu Yoshimachi; Yuji Ikari
Journal:  J Echocardiogr       Date:  2013-09-26

7.  Comparison of arterial lactate levels during sevoflurane versus spinal anesthesia in elderly females undergoing total knee arthroplasty.

Authors:  Hee Yeon Park; Kyung Cheon Lee; Woon Rak Son; Ji Sung Lee; Youn Yi Jo
Journal:  J Anesth       Date:  2014-04       Impact factor: 2.078

8.  Fast-track practice in cardiac surgery: results and predictors of outcome.

Authors:  Marco C Haanschoten; Albert H M van Straten; Joost F ter Woorst; Pieter S Stepaniak; Auke-Dick van der Meer; André A J van Zundert; Mohamed A Soliman Hamad
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-09-05

Review 9.  Clinical review: practical recommendations on the management of perioperative heart failure in cardiac surgery.

Authors:  Alexandre Mebazaa; Antonis A Pitsis; Alain Rudiger; Wolfgang Toller; Dan Longrois; Sven-Erik Ricksten; Ilona Bobek; Stefan De Hert; Georg Wieselthaler; Uwe Schirmer; Ludwig K von Segesser; Michael Sander; Don Poldermans; Marco Ranucci; Peter C J Karpati; Patrick Wouters; Manfred Seeberger; Edith R Schmid; Walter Weder; Ferenc Follath
Journal:  Crit Care       Date:  2010-04-28       Impact factor: 9.097

10.  MicroRNA-21 Mediates Isoflurane-induced Cardioprotection against Ischemia-Reperfusion Injury via Akt/Nitric Oxide Synthase/Mitochondrial Permeability Transition Pore Pathway.

Authors:  Shigang Qiao; Jessica M Olson; Mark Paterson; Yasheng Yan; Ivan Zaja; Yanan Liu; Matthias L Riess; Judy R Kersten; Mingyu Liang; David C Warltier; Zeljko J Bosnjak; Zhi-Dong Ge
Journal:  Anesthesiology       Date:  2015-10       Impact factor: 7.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.